Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts: Gene/Protein Disease Symptom Drug Enzyme Compound   Target Concepts: Gene/Protein Disease Symptom Drug Enzyme Compound

---

Query: EC:3.2.1.36 (hyaluronidase)
4,606 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

We measured lung hyaluronidase activity in rats during postnatal life and during the repair of oxygen-induced lung injury. Hyaluronidase activity increased rapidly after birth and peaked at 16-fold the initial value at 8 days. The peak preceded decreased cell proliferation and the onset of differentiation; this is consistent with current concepts of the role of hyaluronidase. During the repair of lung injury, hyaluronidase activity increased to 2.5-fold the control value at 1 day post-injury, but had decreased by 3 days. This early peak is probably related to simultaneous cell proliferation and differentiation. We postulate that changes in hyaluronidase can influence lung growth and repair and that the system may be amenable to manipulation.
...
PMID:Changes in lung hyaluronidase activity associated with lung growth, injury and repair. 666 Dec 31

Chick embryo fibroblasts constitute a useful model for investigating cell surface differentiation using Ricinus lectin as a marker. Fibroblasts from 8-day chick embryos had two classes of Ricinus lectin binding sites, whereas those from 16-day embryos displayed only one class. Hyaluronidase treatment of fibroblasts from 8-day embryos had no effect on their capacity to bind Ricinus lectin; however after this treatment, 16-day cells resembled 8-day cells since the former also exhibited two classes of lectin-binding sites. Treatment with hyaluronidase released 2-5 times more hyaluronic acid from the older cells than from the younger cells. The same hyaluronidase treatment did not change the number of 8-day cells detached by trypsin from the substrate, but increased the number of detached 16-day cells. These observations suggest (i) that the greater adhesiveness to the substrate of the 16-day cells might be due to the presence on the cell surface of a larger amount of glycosaminoglycans at 16 days than at 8 days, and (ii) that the increased accumulation of hyaluronic acid on the cell surface might be involved in an alteration in the cell membrane during differentiation.
...
PMID:Inaccessibility of certain Ricinus lectin binding sites due to the increase in hyaluronic acid during chick embryo development. 668 62

Proper function of the coronary blood-tissue exchange system may be important in the preservation of myocardium threatened by ischemia. We have undertaken studies aimed at elucidating the functions of this system under baseline and ischemic conditions. The exchange of [14C]sucrose between the coronary capillaries and extravascular space has been studied with the multiple-tracer method. Protein transport has been examined by measuring the deposition of labeled albumin and by collecting cardiac lymph. Results indicate that reduced-flow ischemia decreases functioning capillary surface area but increases permeability to small molecules and protein. Hyaluronidase and adenosine can restore flow after partial occlusion of the coronary artery. However, only hyaluronidase restores capillary surface to its baseline value. Thus, ischemic effects on exchange are not controlled merely by hemodynamic factors. Reduced-flow ischemia in the heart can induce a vascular permeability change in the lung circulation. We conclude that capillary and interstitial transport are altered significantly by ischemia. Preservation of the proper function of these processes may be important in protecting the ischemic myocardium.
...
PMID:Tracer exchange in the normal and ischemic coronary circulation. 669 35

Hyaluronidase has been purified from the venom of the honey bee, Apis mellifera. The purification proved remarkably difficult, requiring a large number of chromatographic steps culminating in the removal of traces of phospholipase A2 with an affinity purified rabbit anti-phospholipase A2 immunosorbent column. The purified enzyme showed a 1143-fold increase in specific activity and was homogeneous. Electrophoresis in polyacrylamide gels (12%) containing sodium dodecyl sulphate (pH 8.9) or urea (pH 2.8) and electrofocusing in polyacrylamide (5%) gave a single band. The final product contained less than 0.1% phospholipase A2 and less than 1.5% acid phosphatase and gave a single line of precipitation against rabbit anti-hyaluronidase but was not precipitated by rabbit anti-phospholipase A2. Previous reports of instability were not confirmed, and we found the enzyme to be highly stable over a wide range of temperature and pH, and to denaturing agents. Purified hyaluronidase was found to be 'sticky' when highly pure and at low concentration, and adhered strongly to Sephadex G-75. The relative molecular mass was estimated at 35 000-37 000 by gel filtration, and at 41 000 by sodium dodecyl sulphate/polyacrylamide gel electrophoresis. A value of 50 000 was obtained by ultracentrifugation assuming a partial specific volume of 0.73 cm3/g. Hyaluronidase was found to be a minor allergen in bee venom allergic patients.
...
PMID:The purification and characterisation of hyaluronidase from the venom of the honey bee, Apis mellifera. 669 11

Seventy-four cultures of Pasteurella multocida representing all four capsular types, A, B, D, and C, from various animal species and diseases were examined for the production of hyaluronidase by two procedures. In one, hyaluronidase production was determined by the depolymerization of streptococcal capsular hyaluronic acid, and in the other, production was determined by degradation of sodium hyaluronidate in a solid culture medium. Hyaluronidase production was only demonstrated in the 13 type B cultures that had been recovered from cases of hemorrhagic septicemia.
...
PMID:Hyaluronidase production by type B Pasteurella multocida from cases of hemorrhagic septicemia. 676 66

Hyaluronidase from rhesus monkey testes was purified by detergent extraction, ammonium sulphate fractionation, Sephadex G-200 column chromatography and concanavalin A-Sepharose affinity chromatography. The purified hyaluronidase showed one protein band on acrylamide gel electrophoresis. Antibodies to the purified hyaluronidase were raised in rabbits and showed a single precipitin line by Ouchterlony gel diffusion. The enzyme had a molecular weight of 62,000. The Km was 0.5 mg/ml for hydrolysis of hyaluronic acid at 37 degrees C. The optimum pH for the enzyme was 5.0 but activity was present over a broad pH range. The hyaluronidase was inhibited by HgCl2, CuSO4, FeSO4 and p-chloromercuribenzoate all at a concentration of 2 x 10(-4) M. Cysteine protected the enzyme against HgCl2 inhibition.
...
PMID:Immunoenzymic studies on testicular hyaluronidase from rhesus monkeys (Macaca mulatta). 680 65

Cell isolates containing multinucleate osteoclasts were obtained from longitudinally split fetal rat long bones by treatment with testicular hyaluronidase. The total yield of osteoclasts and the osteoclast enrichment of the isolate were increased if the intact bones were first cultured for 72 h. Even greater enhancement was obtained if the bones were treated with 1,25-dihydroxycholecalciferol [1,25(OH)2D3] during the culture period. This technique resulted in a cell population containing approximately 15% osteoclasts in yields greater than 50 osteoclasts per long bone. The yield of osteoclasts and the percentage of osteoclasts correlated well with the extent of bone resorption induced by 1,25(OH)2D3. The effectiveness of several isolation procedures was compared using the 1,25(OH)2D3-treated long bones. Conventional digestion with 1 mg/ml crude collagenase gave a much poorer yield of osteoclasts than simply agitating the split long bones. Hyaluronidase plus EDTA was not significantly different from EDTA alone. Even with milder procedures, however, the isolated osteoclasts were damaged as judged by their failure to exclude trypan blue. The osteoclasts are obviously very fragile cells. The isolation technique coupled with May-Grunwald-Giemsa staining permitted reliable determination of the median number of nuclei per osteoclast. This parameter was the same in uncultured bones or in bones cultured for 72 h in control media. Treatment with 1,25(OH)2D3 increased the nuclear number. At lower levels of bone resorption, nuclear number did not increase, but it was significantly greater in more highly resorbed bones.
...
PMID:Isolation of osteoclasts from fetal rat long bones. 681 98

Hyaluronidase, also called the spreading factor, may be an important pathogenic factor for the streptococci. Production of hyaluronidase is found in 75% of human clinical isolates of group B streptococci, and we have in our investigation found the same frequency (74%) in 195 bovine isolates. Of the same 195 isolates 17% turned out to be lactose negative, a characteristic usually regarded as being typical of group B streptococci of human origin. These same strains were also mostly hyaluronidase positive. The parameters investigated: hyaluronidase production, lactose and salicin fermentation and phage-typability, can be useful in tracing the origin of the group B. However, bovine and human streptococcal populations do not seem to be completely distinguishable because overlapping exists between the characteristics.
...
PMID:Hyaluronidase production, lactose and salicin fermentation and phage-typability in bovine group B Streptococci. 703 59

Patients with their first myocardial infarction not initially complicated by severe atrioventricular block or power failure were given a skin test and then randomized to receive either hyaluronidase or placebo in double-blind fashion. Hyaluronidase, 500 IU/kg i.v., was given every 6 hours for 42 hours. Of the 48 eligible patients, 26 received hyaluronidase and 22 received placebo. The mean CK serum entry was 3140 +/- 2111 mIU/ml (mean +/- SD) in hyaluronidase patients and 3574 +/- 1476 mIU/ml in placebo patients (p less than 0.21). The mean infarct size was 54.6 +/- 35.8 CK gram-equivalents in the hyaluronidase patients and 64.0 +/- 31.1 CK gram-equivalents in the placebo patients (p less than 0.20). Among the 21 patients treated within 6 hours of the onset of infarction, the difference in infarct size was greater (p less than 0.15). There was no significant difference in the incidence of power failure, ventricular arrhythmias, recurrence of ischemic pain, infarct extension or mortality. No benefit of hyaluronidase was demonstrated in this study, which was designed to detect a 50% reduction of infarct size. However, to detect a 20% reduction in infarct size would require a much larger study population.
...
PMID:Intravenous hyaluronidase therapy for myocardial infarction in man: double-blind trial to assess infarct size limitation. 706 Feb 55

A biochemical analysis of 66 samples of subretinal fluid from patients with primary rhegmatogenous retinal detachment showed that 46 contained hyaluronic acid. Seventeen samples that did not contain hyaluronic acid disclosed hyaluronidase activity. Hyaluronidase activity in the subretinal fluid increased with the duration of the detachment but there was no correlation between enzyme activity and the age of the patient or the extent of the retinal detachment.
...
PMID:Lysosomal hyaluronidase in the subretinal fluid of patients with rhegmatogenous retinal detachments. 709 Dec 83


<< Previous 1 2 3 4 5 6 7 8 9 10

---